Congress passed the No Surprises Act last year to protect patients from surprise medical bills. This bipartisan legislation was on its way to being celebrated as a victory by all involved—something increasingly rare in Washington, D.C., these days. Unfortunately, insurance companies are already exploiting the way the Biden administration is implementing the law.
Source: Modern Healthcare Today
https://www.modernhealthcare.com/opinion-editorial/insurers-already-exploiting-surprise-billing-law
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more
